| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Anti-inhibitor coagulant complex (substance) |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Microfibrillar collagen hemostat |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Absorbable gelatin film (substance) |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Absorbable gelatin powder |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Recombinant coagulation factor VIIa |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Thrombin agent |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Factor IX complex |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminocaproic acid |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Human antihemophilic plasma |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbazochrome salicylate |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Plasma substitutes (substance) |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Coagulant (substance) |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Antihemophilic factor agent (substance) |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Local application of hemostyptics onto gastric lesion |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| traitement par injection d'une lésion de duodénum |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Local application of haemostyptics onto duodenal lesion |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| agent hémostatique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hemostatic adverse reaction |
Causative agent (attribute) |
True |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ethamsylate adverse reaction (disorder) |
Causative agent (attribute) |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Collagen adverse reaction |
Causative agent (attribute) |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to hemostatic agent |
Causative agent (attribute) |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ethamsylate allergy |
Causative agent (attribute) |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to collagen |
Causative agent (attribute) |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Endoscopic application of hemostyptics to gastric lesion |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| injection hémostatique d'une lésion duodénale |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| injection hémostatique d'une lésion gastrique |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| injection d'adrénaline à visée hémostatique pour une lésion gastrique |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Injection of epinephrine into lesion of duodenum for hemostasis |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Endoscopic injection haemostasis of duodenal ulcer |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Endoscopic injection hemostasis of gastric ulcer (procedure) |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fibrinolytic drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Antifibrinolytic drugs and hemostatics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing etamsylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Etamsylate 250mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Etamsylate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Collagen [hemostatic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing human fibrinogen and thrombin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Desmopressin acetate 10micrograms nasal spray (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Desmopressin acetate 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely desmopressin acetate 200 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Desmopressin acetate 100micrograms/1mL intranasal solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| acétate de desmopressine 4 microgrammes/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Succinylated gelatin 4% infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing collagen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Application of chemical haemostatic agents |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Factor ix complex 100% (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Desmopressin acetate 1.5mg/mL spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Antihemophilic factor 500unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Desmopressin acetate 0.01% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Desmopressin acetate 0.1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Desmopressin acetate 0.2mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Desmopressin acetate 0.1mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Desmopressin acetate 0.01% spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tranexamic acid (substance) |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aprotinin (substance) |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tissue factor, the high-affinity receptor and cofactor for the plasma serine protease VII/VIIa |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Etamsylate |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing desmopressin acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing antihemophilic factor agent (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Desmopressin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Factor VIII fraction products (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Factor IX fraction products (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Recombinant coagulation factor IX 250iu injection (pdr for recon)+solvent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| facteur IX de coagulation recombinant 500 U.I., fiole de poudre et solvant pour solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| facteur IX de coagulation recombinant 1 000 U.I., fiole de poudre et solvant pour solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing coagulation factor VIIa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| facteur VIIa de coagulation recombinant 60 000 U.I., fiole de poudre et solvant pour solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Recombinant coagulation factor VIIa 120,000iu injection kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Recombinant coagulation factor VIIa 240,000iu injection kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Coagulation factor VIII- and von Willebrand factor-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Factor VIII+von Willebrand factor 500iu/1100iu injection (pdr for recon)+diluent+kit (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Factor VIII+von Willebrand factor 1000iu/2200iu injection (pdr for recon)+diluent+kit (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Coagulation factor XIII-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| facteur XIII 250 unités, fiole de poudre et solvant pour solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Factor XIII 1250units injection (pdr for recon)+diluent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acset |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing high purity factor IX |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intermediate factor IX (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing anti-inhibitor coagulant complex (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing factor IX concentrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Factor V concentrate products |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| facteur VII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| DNA factor VIII (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing high purity factor VIII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intermediate factor VIII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing porcine factor VIII (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Factor VIII by-passing fraction products (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Coagulation factor XI-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| von Willebrand factor-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dried factor IX fraction heated 600iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Factor VIII by-passing fraction 500iu injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Factor VIII by-passing fraction 1000iu injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| High purity factor VIII fraction 250iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| High purity factor VIII fraction 500iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| High purity factor VIII fraction 1000iu injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intermediate factor VIII fraction 250iu injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intermediate factor VIII fraction 500iu injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Porcine factor VIII 700iu injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| High purity factor IX 250iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| High purity factor IX 500iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| High purity factor IX 1000iu injection kit (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]